SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,934,000 | -45.3% | 335,000 | -36.8% | 13.38% | -13.5% |
| Q2 2021 | $16,319,000 | +16.7% | 530,000 | -0.7% | 15.46% | +38.9% |
| Q1 2021 | $13,980,000 | +19.5% | 534,000 | +14.8% | 11.13% | +43.7% |
| Q4 2020 | $11,699,000 | -13.9% | 465,000 | -13.6% | 7.75% | -38.1% |
| Q4 2016 | $13,591,000 | +44.8% | 538,241 | +41.8% | 12.52% | +79.3% |
| Q3 2016 | $9,386,000 | -29.9% | 379,533 | -42.3% | 6.98% | +13.7% |
| Q2 2016 | $13,394,000 | -2.8% | 657,533 | -27.2% | 6.14% | -4.8% |
| Q1 2016 | $13,779,000 | -2.5% | 903,533 | -14.1% | 6.45% | -3.0% |
| Q4 2015 | $14,129,000 | +28.7% | 1,051,277 | +34.3% | 6.65% | +2.4% |
| Q3 2015 | $10,982,000 | – | 782,746 | – | 6.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |